| 18.82 Delayed Data As of Sep 13 |  -0.19 / -1.00%Today’s Change | 11.31 Today|||52-Week Range 33.13 | +43.45% Year-to-Date |
| Previous close | 19.01 |
| Today’s open | 19.00 |
| Day’s range | 18.67 - 19.34 |
| Volume | 685,787 |
| Average volume (3 months) | 1,169,089 |
| Market cap | $1.7B |
| Earnings growth (last year) | -45.93% |
| Earnings growth (this year) | +28.80% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 102.57 |
| Price/Book | 6.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| IRWDIronwood Pharmaceuti... | -0.05 | -0.52% |
| CORTCorcept Therapeutics... | -0.03 | -0.22% |
| MDGLMadrigal Pharmaceuti... | -6.11 | -6.06% |
| SUPNSupernus Pharmaceuti... | -0.36 | -1.29% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $9.8M |
| Annual profit (last year) | -$324.3M |
| Net profit margin | -3,297.17% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Will Lewis |
Chief Technology Officer Walter R. Perkins |
Corporate headquarters Bridgewater, New Jersey |
